EAGLE PHARMACEUTICALS, INC. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EAGLE PHARMACEUTICALS, INC. for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | RIGGS DAVID E | Chief Financial Off ... | Option Exercise | A | 84.92 | 40,000 | 3,396,800 | 40,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Graves Michael | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Glenning Robert | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | RATOFF STEVEN B | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 84.92 | 200,900 | 17,060,428 | 200,900 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | A | 84.92 | 42,000 | 3,566,640 | 42,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Option Exercise | A | 84.92 | 90,000 | 7,642,800 | 90,000 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Option Exercise | A | 84.92 | 67,200 | 5,706,624 | 67,200 | |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 85.16 | 65,114 | 5,545,108 | 3,879,287 | 3.9 M to 3.9 M (-1.65 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 46.09 | 5,127 | 236,303 | 53,464 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 46.09 | 5,126 | 236,257 | 58,591 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 46.09 | 7,569 | 348,855 | 63,717 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 2,683 | 33,886 | 20,000 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 10,000 | 126,300 | 22,683 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 7,317 | 92,414 | 32,683 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 2,683 | 33,994 | 8,952 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 6,270 | 79,441 | 11,635 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 4.42 | 3,730 | 16,487 | 5,480 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 78.61 | 5,127 | 403,018 | 0 | 5.1 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 46.09 | 5,127 | 236,303 | 5,127 | 0 to 5.1 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 76.78 | 5,126 | 393,571 | 0 | 5.1 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 46.09 | 5,126 | 236,257 | 5,126 | 0 to 5.1 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 77.17 | 7,569 | 584,135 | 0 | 7.6 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 46.09 | 7,569 | 348,855 | 7,569 | 0 to 7.6 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 77.17 | 2,683 | 207,060 | 0 | 2.7 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 2,683 | 33,886 | 2,683 | 0 to 2.7 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 76.69 | 10,000 | 766,876 | 0 | 10 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 10,000 | 126,300 | 10,000 | 0 to 10 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 75.61 | 7,317 | 553,213 | 0 | 7.3 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 7,317 | 92,414 | 7,317 | 0 to 7.3 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 75.61 | 2,683 | 202,853 | 0 | 2.7 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 2,683 | 33,994 | 2,683 | 0 to 2.7 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 74.79 | 6,270 | 468,931 | 0 | 6.3 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 6,270 | 79,441 | 6,270 | 0 to 6.3 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 74.79 | 3,730 | 278,965 | 0 | 3.7 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 4.42 | 3,730 | 16,487 | 3,730 | 0 to 3.7 K |